Attenuated Toxoplasma gondii enhances the antitumor efficacy of anti-PD1 antibody by altering the tumor microenvironment in a pancreatic cancer mouse model

被引：0
|
作者：
Said Ahmed Bahwal
Jane J. Chen
Lilin E
Taofang Hao
Jiancong Chen
Vern B. Carruthers
Jiaming Lai
Xingwang Zhou
机构：
[1] Sun Yat-Sen University,Department of Biochemistry and Molecular Biology, Sun Yat
[2] Warren Alpert Medical School of Brown University,Sen University Zhongshan School of Medicine
[3] Sun Yat-Sen University,Department of Pancreato
[4] University of Michigan School of Medicine,Biliary Surgery, The First Affiliated Hospital
来源：
Journal of Cancer Research and Clinical Oncology | 2022年 / 148卷
关键词：
Dendritic cells; Immunotherapy; Programmed cell death 1 receptor; Vaccination;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2743 / 2757
页数：14
相关论文
共 50 条
  • [21] DSP-0692, a selective SCD inhibitor, enhances the anti-tumor activity of anti-PD1 antibody
    Sugaru, Eiji
    Furuta, Yudai
    Nagagaki, Yoshikazu
    Ikeda, Satoshi
    Fukunaga, Yuichi
    Urnehara, Hiroki
    Otsubo, Tsuguteru
    Watanabe, Manabu
    Tojo, Shingo
    Hashizume, Miki
    Matsuki, Yasushi
    Ban, Hitoshi
    CANCER RESEARCH, 2019, 79 (13)
  • [22] Disruption of CXCR2-Mediated MDSC Tumor Trafficking Enhances Anti-PD1 Efficacy
    Highfill, Steven L.
    Cui, Yongzhi
    Giles, Amber J.
    Smith, Jillian P.
    Zhang, Hua
    Morse, Elizabeth
    Kaplan, Rosandra N.
    Mackall, Crystal L.
    SCIENCE TRANSLATIONAL MEDICINE, 2014, 6 (237)
  • [23] Altering the tumor microenvironment to improve immunotherapy: Molecular imaging of PD-L1 in pancreatic cancer
    Henry, Kelly
    Davydova, Maria
    Dilling, Thomas
    Fox, Ian
    Lewis, Jason
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 258
  • [24] NEOADJUVANT IMMUNOTHERAPY WITH ANTI-PD1 ALTERS THE TUMOR MICROENVIRONMENT POST SURGERY IN A MODEL OF RECURRENT GLIOBLASTOMA
    Hoang-Minh, Lan
    Doonan, Bently
    von Roemeling, Christina
    Yang, Changlin
    Shin, David
    Trivedi, Vrunda
    Karachi, Aida
    Wang, Yu
    Mitchell, Duane
    NEURO-ONCOLOGY, 2021, 23 : 168 - 168
  • [25] Anti-Siglec 7 antibody displays potent antitumor immunity and demonstrates improved tumor control in combination with anti-PD1 in ovarian cancer
    Bordoloi, Devivasha
    Kulkarni, Abhijeet J.
    Adeniji, Opeyemi S.
    Pampena, M. Betina
    Bhojnagarwala, Pratik S.
    Zhao, Shushu
    Parzych, Elizabeth M.
    Zhang, Rugang
    Betts, Michael R.
    Abdel-Mohsen, Mohamed
    Weiner, David B.
    CANCER RESEARCH, 2023, 83 (07)
  • [26] Interferon gamma inhibits CXCL8-CXCR2 axis mediated tumor-associated macrophages tumor trafficking and enhances anti-PD1 efficacy in pancreatic cancer
    Zhang, Mingjie
    Huang, Lifeng
    Ding, Guoping
    Huang, Huilian
    Cao, Guoliang
    Sun, Xu
    Lou, Neng
    Wei, Qiang
    Shen, Tao
    Xu, Xiaodong
    Cao, Liping
    Yan, Qiang
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (01)
  • [27] Epigenetic modulation of the tumor microenvironment enhances immune checkpoint efficacy in a murine model of pancreatic cancer
    Christmas, Brian
    Scott, Blake
    Armstrong, Todd
    Azad, Nilofer
    Jaffee, Elizabeth
    CANCER RESEARCH, 2018, 78 (13)
  • [28] Anti-PD1 antibody and not anti-LAG-3 antibody improves the antitumor effect of photodynamic therapy for treating metastatic breast cancer
    Long, Shan
    Zhao, Yibing
    Xu, Yuanyuan
    Wang, Bo
    Qiu, Haixia
    Zhao, Hongyou
    Zeng, Jing
    Chen, Defu
    Li, Hui
    Shao, Jiakang
    Li, Xiaosong
    Gu, Ying
    JOURNAL OF INNOVATIVE OPTICAL HEALTH SCIENCES, 2024, 17 (01)
  • [29] Regorafenib enhances anti-PD1 immunotherapy efficacy in murine colorectal cancers and their combination prevents tumor regrowth
    Doleschel, Dennis
    Hoff, Sabine
    Koletnik, Susanne
    Rix, Anne
    Zopf, Dieter
    Kiessling, Fabian
    Lederle, Wiltrud
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2021, 40 (01)
  • [30] Regorafenib enhances anti-PD1 immunotherapy efficacy in murine colorectal cancers and their combination prevents tumor regrowth
    Dennis Doleschel
    Sabine Hoff
    Susanne Koletnik
    Anne Rix
    Dieter Zopf
    Fabian Kiessling
    Wiltrud Lederle
    Journal of Experimental & Clinical Cancer Research, 40
12345